Metabolic consequences of peritoneal dialysis

Seminars in Dialysis

Volumn 17, Issue 6, 2004, Pages 498-504

  Burkart, John ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; GLUCOSE; ICODEXTRIN; INSULIN; OSMOTIC AGENT; POLYPEPTIDE;

ACUTE KIDNEY FAILURE; BLOOD STORAGE; CALORIE; COLLOID; CRYSTALLOID; DIALYSATE; DIET SUPPLEMENTATION; EXTRACELLULAR SPACE; GLOMERULUS FILTRATION; GLUCOSE ABSORPTION; HEALTH HAZARD; HEMODIALYSIS; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; HYPERLIPIDEMIA; KIDNEY METABOLISM; KIDNEY TUBULE ABSORPTION; LIQUID; MACROMOLECULE; MEMBRANE TRANSPORT; ONCOTIC PRESSURE; PERITONEAL DIALYSIS; PERITONITIS; PROTEIN DEPLETION; PROTEIN MALNUTRITION; RASH; REVIEW; ULTRAFILTRATION; UREMIA;

AMINO ACIDS; DIALYSIS SOLUTIONS; ENERGY INTAKE; GLUCANS; GLUCOSE; HEMOFILTRATION; HUMANS; OSMOSIS; PERITONEAL DIALYSIS; SWEETENING AGENTS;

EID: 12144284008     PISSN: 08940959     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0894-0959.2004.17610.x     Document Type: Review

References (56)

1. Eknoyan G, Beck GJ, Cheung AK, Daugirdas JT, Greene T, Kusek JW, Allon M, Bailey J, Delmez JA, Depner TA, Dwyer JT, Levey AS, Levin NW, Milford E, Ornt DB, Rocco MV, Schulman G, Schwab SJ, Teehan BP, Toto R: Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 347:210-2019, 2002
2. Paniagua R, Amato D, Vonesh E, Correa-Rotter R, Ramos A, Morgan J, Mujais S: Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol 13:1307-1320, 2002
3. Lo WK, Ho YW, Li CS, Wong KS, Chan TM, Yu AWY, Ng FSK, Cheng IKP: Effect of Kt/V on survival and clinical outcome in CAPD patients in a randomized prospective study. Kidney Int 64:649-656, 2003
4. Lindholm B, Bergstrom J: Nutritional aspects of CAPD. In: Gokal R (ed). Continuous Ambulatory Peritoneal Dialysis. Edinburgh: Churchill Livingstone, 1986:228
5. Gokal R, Ramos J, McGurk J, Ward MK, Kerr DNS: Hyperlipidemia in patients on continuous ambulatory peritoneal dialysis. In: Gahl GM, Kessel M, Nolph KD (eds). Advances in Peritoneal Dialysis. Amsterdam: Excerpta Medica, 1981:430
6. Bouma S, Dwyer JT: Glucose absorption and weight exchange in 18 months of continuous ambulatory peritoneal dialysis. J Am Diet Assoc 84:194-197, 1984
7. Oreopoulos DG, Crassweller P, Kartirtzoglou A, et al.: Amino acids as an osmotic agent (instead of glucose) in continuous ambulatory peritoneal dialysis. In: Legrain M (ed). First International Symposium on CAPD. Paris: Excerpta Medica, 1979:335
8. Williams PF, Marliss E, Anderson GH, Oren A, Khanna R, Petitt J, Brandes L, Rodella H, Mupas L, Dombros N, Oreopoulos DG: Amino acid absorption following intraperitoneal administration in CAPD patients. Perit Dial Bull 2:124-130, 1982
9. Oren A, Wu G, Anderson GH, Marliss E, Khanna R, Pettit J, Mupas L, Rodella H, Brandes L, Roncari DA, Kakis G, Harrison J, McNeil K, Oreopoulos DG: Effective use of amino acid dialysate over four weeks in CAPD patients. Perit Dial Bull 3:66-73, 1983
10. Dombros N, Prutis K, Tong M, Anderson GH, Harrison J, Sombolos K, Digenis G, Pettit J, Oreopoulos DG: Six-month overnight intraperitoneal amino acid infusion in continuous ambulatory peritoneal dialysis patients - no effect on nutritional status. Perit Dial Int 10:79-84, 1990
11. Jones MR, Gehr T, Burkart JM, Hamburger RJ, Kraus AP Jr, Piranio BM, Hagen T, Ogrinc FG, Wolfson M: Replacement of amino acid and protein losses with 1.1% amino acid and protein losses with 1.1% amino acid peritoneal dialysis solution. Perit Dial Int 18:210-216, 1998
12. Klein E, Ward A, Williams TE, Feldhoff PW: Peptides as substitute osmotic agents for glucose in peritoneal dialysate. ASAIO J 32:550, 1986
13. Martis L, Burke R, Klein E: Evaluation of a peptide-based solution for peritoneal dialysis. Perit Dial Int 13(suppl):92, 1993
14. Woodrow G, Stables G, Oldroyd B, Gibson J, Turney JH, Brownjohn AM: Comparison of Icodextrin and glucose solutions for the daytime dwell in automated peritoneal dialysis. Nephrol Dial Transplant 14:1530-1535, 1999
15. Rubin J, Klein E, Jones Q, Planch JA, Bower J: Evaluation of a polymer dialysate. ASAIO J 29:62, 1983
16. Higgins JT, Gross ML, Somani P: Patient tolerance and dialysis effectiveness of a glucose polymer-containing peritoneal dialysis solution. Perit Dial Bull 4(suppl):S131-S133, 1984
17. Gokal R, Mistry CD: Glucose polymer as an osmotic agent in CAPD. In: La Graeca G, Ronco C, Feriani M (eds). Fourth International Course on Peritoneal Dialysis. Venice: Wichtig Editore, 1991:119
18. Mistry CD, Fox J, Mallick N, Gokal R: Circulating maltose and isomaltose in chronic renal failure. Kidney Int Suppl 22:210, 1987
19. Williams PF, Foggensteiner L: Allergic peritonitis with icodextrin in CAPD patients. Perit Dial Int 22:89-90, 2002
20. Bredie SJH, Bosch FH, Demaacker PNM, Stalenhoef AF, van Leusen R: Effects of peritoneal dialysis with an overnight dwell on parameters of glucose and lipid metabolism. Pent Dial Int 21:275-281, 2001
21. Amicil G: Hyperinsulinemia reduction associated with Icodextrin treatment in CAPD patients. Perit Dial Int 21(suppl):22, 2001
22. Podel J, Hodelin-Wetzel R, Saha D, Burns G: Glucose absorption in acute peritoneal dialysis. J Ren Nutr 10:93-97, 2000
23. Amstrong VW, Cruetzfeldt W, Ebert R, Fuchs C, Hilgers R, Scheler F: Effect of dialysate glucose load on plasma and glucoregulatory hormones in CAPD patients. Nephron 39:141, 1985
24. Von Baeyer H, Gahl GM, Riedinger H, Borowzac R, Averdunk R, Schurig R, Kessel M: Adaptation of CAPD patients to continuous peritoneal energy uptake. Kidney Int 23:29-34, 1983
25. Lindholm B, Bergstrom J: Nutritional management of patients undergoing peritoneal dialysis. In: Nolph KD (ed). Peritoneal Dialysis. Dordrecht: Kluwer, 1989:320
26. DeSanto NG, Capodicasa G, Senatore R, Cicchetti T, Cirillo D, Damiano M, Torella R, Giugliano D, Improta L, Giordano C: Glucose utilization from dialysate in patients on continuous peritoneal dialysis. Int J Artif Organs 2:119, 1978
27. Grodstein GP, Blumenkrantz MJ, Kopple JD, Moran KJ, Coburn JW: Glucose absorption during continuous ambulatory peritoneal dialysis. Kidney Int 19:564-567, 1981
28. Davies SJ, Russell L, Bryan J, Phillips L, Russell GI: Impact of peritoneal absorption of glucose on appetite, protein catabolism and survival in CAPD patients. Clin Nephrol 45:194-198, 1996
29. Bergstrom J, Furst P, Alvesstrand A, Lindholm B: Protein and energy intake, nitrogen balance and nitrogen losses in patients treated with continuous ambulatory peritoneal dialysis. Kidney Int 44:1048-1057, 1993
30. Bergstrom J, Lindholm B: Nutrition and adequacy of dialysis. How do hemodialysis and CAPD compare? Kidney Int Suppl 40:S39-S50, 1993
31. Manji N, Shikora S, McMahon M, Blackburn GL, Bistrian BR: Peritoneal dialysis for acute renal failure: overfeeding resulting from dextrose absorbed during dialysis. Crit Care Med 18:29-31, 1990
32. Vonesh EF, Lysaght MJ, Moran J, Farrell P: Kinetic modeling as a prescription aid in peritoneal dialysis. Blood Purif 9:246-245, 1991
33. Vonesh EF, Keshaviah PR: Applications in kinetic modeling using PD ADEQUEST. Perit Dial Int 17(suppl 2):S119-S125, 1997
34. Mistry CD, Gokal R, Peers EM: A randomized multicenter clinical trial comparing isosmolar icodextrin with hyperosmolar glucose solutions in CAPD. MIDAS Study Group. Multicenter investigation of icodextrin in ambulatory peritoneal dialysis. Kidney Int 46:496-503, 1994
35. Bajo MA, Selgas R, Hevia C, Castro MJ, Aguilera A, Millan I, Sanchez C, del Peso G: Icodextrin 7.5% dialysate for diurnal exchange in patients treated with CCPD [abstract]. Perit Dial Int 19(suppl 1):S49, 1999
36. Amici G, Orrasch M, Da Rin G, Bocci C: Hyperinsulinism reduction associated with icodextrin treatment in continuous ambulatory peritoneal dialysis patients. Adv Perit Dial 17:80-84, 2001
37. Data on file, Baxter Healthcare Corporation
38. Jones MR, Martis L, Algrim CE, Bernard D, Swartz R, Messena J, Bergstrom J, Lindholm B, Lim V, Serkes KD, Vonesh E, Kopple JD: Amino acid solutions for CAPD: rationale and clinical experience. Miner Electrolyte Metab 18:309-315, 1992
39. Kopple JD, Blumenkrantz MJ, Jones MR, Moran JK, Coburn JW: Plasma amino acid levels and amino acid losses during continuous ambulatory peritoneal dialysis. Am J Clin Nut 36:395, 1982
40. Young GA, Dibble JB, Hobson SM, Tompkins L, Gibson J, Turney JH, Brownjohn AM: The use of an amino acid based CAPD solution over 12 weeks. Nephrol Dial Transplant 4:285-292, 1989
41. Pedersen FB, Dragsholt C, Laier E, Frifelt JJ, Trostmann AF, Ekelund S, Paaby P: Alternate use of amino acid and glucose solutions in CAPD. Perit Dial Bull: 215-218, 1985
42. Kopple JD, Bernard D, Brunori G, Swartz R, Messana J, Bergstrom J, Lindholm B, Lim V, Anderson GH, Oreopoulos DG, Algrim C, Jones M, Serkes K, Vonesh E, Martis L: Nutritional effects of intraperitoenal (IP) amino acids (AA) in malnourished CAPD patients. J Am Soc Nephrol 2:362, 1991
43. Bruno M, Bagnis C, Marangella M, Rovera L, Cantaluppi A, Linari F: CAPD with an amino acid dialysis solution: a long-term cross-over study. Kidney Int 35:1189-1194, 1989
44. Prichard SS, Cianflone K, Zhang ZJ, Sniderman A. A novel mechanism to explain the dyslipidemia in CAPD and nephrotic patients. Perit Dial Int 12:150, 1992
45. Williams PFM, Arliss EB, Anderson GH, Oren A, Stein AN, Khanna R, Pettit J, Brandes L, Rodella H, Mupas L, Dombros N, Oreopoulos DG: Amino acid absorption following intraperitoneal absorption in CAPD patients. Perit Dial Bull: 124-130, 1982
46. Gjessing J: Addition of amino acids to peritoneal-dialysis fluid. Lancet 2:812, 1968
47. Hanning RM, Balfe JW, Zlotkin SH: Effectiveness and nutritional consequences of amino acid based glucose-based dialysis solutions in infants and children receiving CAPD. Am J Clin Nutr 46:22-30, 1987
48. Faller B: Amino acids based peritoneal solutions. Kidney Int Suppl 56:81-85, 1996
49. Jones M, Hagen T, Boyle CA, Vonesh E, Hamburger R, Charytan C, Sandroni S, Bernard D, Piraino B, Schreiber M, Gehr T, Fien P, Friedlander M, Burkart J, Ross D, Zimmerman S, Swartz R, Knight T, Kraua A Jr. McDonald L, Hartnett M, Weaver M, Martis L: Treatment of malnutrition with 1.1% amino acid peritoneal dialysis solutions: results of a multicenter outpatient study. Am J Kidney Dis 32:761-769, 1998
50. Young GA, Kopple JD, Linholm B, Vonesh EF, Vecchi A, Scalamogna A, Castelnova C, Oreopoulos DG, Anderson GH, Bergstrom J: Nutritional assessment of continuous peritoneal dialysis patients: an international study. Am J Kidney Dis 17:462-471, 1991
51. Gahl GM, Baeyer HV, Riedinger RF, Borowzak B, Schurig R, Becker H, Kessel M: Caloric intake in patients undergoing CAPD. In: Moncrief JW, Popovich RP (eds). CAPD Update. New York: Masson, 1981:87-93
52. Dombros N, Oren A, Marliss EB, Anderson GH, Stein AN, Khanna R, Petit J, Brandes L, Rodella H, Leibel BS, Oreopoulos D: Plasma amino acid profiles and amino acid losses in patients undergoing CAPD. Perit Dial Bull: 27-32, 198
53. Young GA, Brownjohn AM, Parsons FM: Protein losses in patients receiving continuous ambulatory peritoneal dialysis. Nephron 45:196-201, 1987
54. Dulaney JT, Hatch FE Jr: Peritoneal dialysis and loss of proteins: a review. Kidney Int 26:253-262, 1984
55. Blumenkrantz MJ, Kopple JD, Moran KJ, Coburn JW: Metabolic balance studies and dietary protein requirements in patients undergoing continuous peritoneal dialysis. Kidney Int 21:849-861, 1982
56. NKF-K/DOQI Clinical Practice Guidelines for Peritoneal Dialysis Adequacy. New York: National Kidney Foundation, 2001